bioRxiv ScienceSearch

bioRxiv · 10.1101/634758

When 90% of the variance is not enough: residual EMG from muscle synergy extraction influences task performance

Abstract

Muscle synergies are usually identified via dimensionality reduction techniques, such that the identified synergies reconstruct the muscle activity to a level of accuracy defined heuristically, such as 90% of the variance explained. Here, we question the assumption that the residual muscle activity not explained by the synergies is due to noise. We hypothesize instead that the residual activity is structured and can therefore influence the execution of a motor task. Young healthy subjects performed an isometric reaching task in which surface electromyography of 10 arm muscles was mapped onto estimated two-dimensional forces used to control a cursor. Three to five synergies were extracted to account for 90% of the variance explained. We then altered the muscle-force mapping via \"hard\" and \"easy\" virtual surgeries. Whereas in both surgeries the forces associated with synergies spanned the same single dimension of the virtual environment, the muscle-force mapping was as close as possible to the initial mapping in the easy surgery and as far as possible in the hard surgery. This design therefore maximized potential differences in reaching errors attributable to the residual muscle activity. Results show that the easy surgery produced much smaller directional errors than the hard task. In addition, systematic estimations of the errors for easy and hard surgeries constructed with 1 to 10 synergies show that the errors differ significantly for up to 8 synergies, which account for 98% of the variance on average. Our study therefore indicates the need for cautious interpretations of results derived from synergy extraction techniques based on heuristics with lenient levels of accuracy.\n\nAuthor summaryThe muscle synergy hypothesis states that the central nervous system simplifies motor control by grouping muscles that share common functions into modules called muscle synergies. Current techniques use unsupervised dimensionality reduction algorithms to identify these synergies. However, these techniques rely on arbitrary criteria to determine the number of synergies, which is actually unknown. An example of such criteria is that the identified synergies must be able to reconstruct the measured muscle activity to at least a 90% level of accuracy. Thus, the residual muscle activity, the remaining 10% of the muscle activity, is often disregarded as noise. We show that residual muscle activity following muscle synergy identification has a large systematic effect on movements even when the number of synergies approaches the number of muscles. This suggests that current synergy extraction techniques may discard a component of muscle activity that is important for motor control. Therefore, current synergy extraction techniques must be updated to identify true physiological synergies.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Barradas, V. R., Kutch, J. J., Kawase, T., Koike, Y., Schweighofer, N.. 2019-05-13. When 90% of the variance is not enough: residual EMG from muscle synergy extraction influences task performance. https://doi.org/10.1101/634758

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience